Literature DB >> 8551230

HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis.

G H Nabozny1, J M Baisch, S Cheng, D Cosgrove, M M Griffiths, H S Luthra, C S David.   

Abstract

Genetic studies have indicated that susceptibility to rheumatoid arthritis (RA) maps to the HLA-DR locus of the major histocompatibility complex. Strong linkage disequilibrium between certain HLA-DQ genes and HLA-DR genes associated with RA, however, suggests that HLA-DQ molecules may also play a role in RA susceptibility. To examine the role of HLA-DQ molecules in arthritis, we generated transgenic mice expressing the DQA1*0301 and DQB1*0302 genes from an RA predisposing haplotype (DQ8/DR4Dw4). The transgenes were introduced into mouse class II-deficient H-2Ab0 mice, and their susceptibility to experimental collagen-induced arthritis was evaluated. The HLA-DQ8+,H-2Ab0 mice displayed good expression of the DQ8 molecule, while no surface expression of endogenous murine class II molecules could be detected. The DQ8 molecule also induced the selection of CD4+ T cells expressing a normal repertoire of V beta T cell receptors. Immunization of HLA-DQ8+,H-2Ab0 mice with bovine type II collagen (CII) induced a strong antibody response that was cross-reactive to homologous mouse CII. Also, in vitro proliferative responses against bovine CII, which were blocked in the presence of an antibody specific for HLA-DQ and mouse CD4, were detected. Finally, a severe polyarthritis developed in a majority of HLA-DQ8+,H-2Ab0 mice, which was indistinguishable from the disease observed in arthritis susceptible B10.T(6R) (H-2Aq) controls. In contrast, HLA-DQ8-,H-2Ab0 fullsibs did not generate CII antibody and were completely resistant to arthritis. Therefore, these results strongly suggest that HLA-DQ8 molecules contribute to genetic susceptibility to arthritis and also establish a novel animal model for the study of human arthritis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551230      PMCID: PMC2192409          DOI: 10.1084/jem.183.1.27

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  53 in total

1.  Correlation between the V beta 4+ CD8+ T-cell population and the H-2d haplotype.

Authors:  K Tomonari; E Lovering; S Spencer
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  HLA-DQ beta 3.1 allele is a determinant of susceptibility to DR4-associated rheumatoid arthritis.

Authors:  J S Lanchbury; L I Sakkas; S G Marsh; J G Bodmer; K I Welsh; G S Panayi
Journal:  Hum Immunol       Date:  1989-09       Impact factor: 2.850

3.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

4.  Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus.

Authors:  J M Baisch; T Weeks; R Giles; M Hoover; P Stastny; J D Capra
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

5.  Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response.

Authors:  L Fugger; S A Michie; I Rulifson; C B Lock; G S McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

6.  Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice.

Authors:  S K Lawrance; L Karlsson; J Price; V Quaranta; Y Ron; J Sprent; P A Peterson
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

Review 7.  Mechanisms of immune injury in rheumatoid arthritis: evidence for the involvement of T cells and heat-shock protein.

Authors:  S Strober; J Holoshitz
Journal:  Immunol Rev       Date:  1990-12       Impact factor: 12.988

8.  Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures.

Authors:  K Miyake; K L Medina; S Hayashi; S Ono; T Hamaoka; P W Kincade
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

9.  Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.

Authors:  K Yamamoto; Y Fukui; Y Esaki; T Inamitsu; T Sudo; K Yamane; N Kamikawaji; A Kimura; T Sasazuki
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

10.  Human major histocompatibility complex class II-restricted T cell responses in transgenic mice.

Authors:  A Woods; H Y Chen; M E Trumbauer; A Sirotina; R Cummings; D M Zaller
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  52 in total

Review 1.  Association of MHC and rheumatoid arthritis. Regulatory role of HLA class II molecules in animal models of RA: studies on transgenic/knockout mice.

Authors:  V Taneja; C S David
Journal:  Arthritis Res       Date:  2000-04-12

2.  Evaluating candidate autoantigens in rheumatoid arthritis.

Authors:  A P Cope; G Sønderstrup
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.

Authors:  E C Andersson; B E Hansen; H Jacobsen; L S Madsen; C B Andersen; J Engberg; J B Rothbard; G S McDevitt; V Malmström; R Holmdahl; A Svejgaard; L Fugger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 4.  Gene therapy for rheumatoid arthritis. Theoretical considerations.

Authors:  Y Chernajovsky; A Annenkov; C Herman; K Triantaphyllopoulos; D Gould; H Dreja; S P Moyes; J L Croxford; R A Mageed; O L Podhajcer; D Baker
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 5.  B cells as effectors and regulators of sex-biased arthritis.

Authors:  David Luckey; Kay Medina; Veena Taneja
Journal:  Autoimmunity       Date:  2012-08       Impact factor: 2.815

Review 6.  HLA transgenic mice as humanized mouse models of disease and immunity.

Authors:  V Taneja; C S David
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

7.  Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice.

Authors:  A Geluk; V Taneja; K E van Meijgaarden; E Zanelli; C Abou-Zeid; J E Thole; R R de Vries; C S David; T H Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.

Authors:  L Wen; F S Wong; L Burkly; M Altieri; C Mamalaki; D Kioussis; R A Flavell; R S Sherwin
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigens.

Authors:  Chao Jiang; Umesh S Deshmukh; Felicia Gaskin; Harini Bagavant; Julie Hanson; Chella S David; Shu Man Fu
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

10.  Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice.

Authors:  J C Flynn; A Gardas; Q Wan; M Gora; G Alsharabi; W Z Wei; A A Giraldo; C S David; Y M Kong; J P Banga
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.